BioLineRx (BLRX) Goodwill & Intangibles (2012 - 2025)

BioLineRx's Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $16.4 million for Q4 2025.

• In Q4 2025, Goodwill & Intangibles rose 56.65% year-over-year to $16.4 million; the TTM figure through Dec 2025 stood at $16.4 million (up 56.65% YoY), while the FY2025 annual figure was $16.4 million, up 56.65% from the prior year.
• Goodwill & Intangibles was $16.4 million for Q4 2025 at BioLineRx, up from $10.4 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $22.0 million in Q3 2023 to a low of $10.4 million in Q3 2025.
• Historically, Goodwill & Intangibles has averaged $17.8 million across 5 years, with a median of $21.7 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles sank 51.04% in 2024, then surged 56.65% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $21.7 million in 2021, then climbed by 0.06% to $21.7 million in 2022, then fell by 1.72% to $21.3 million in 2023, then tumbled by 51.04% to $10.4 million in 2024, then soared by 56.65% to $16.4 million in 2025.
• The last three Goodwill & Intangibles figures came in at $16.4 million (Q4 2025), $10.4 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.